tiselizumab

First FDA filing for Novartis’ latecomer PD-1 drug tislelizumab
Pharmaforum
Mon, 09/13/21 - 10:26 am
Novartis
tiselizumab
FDA
esophageal cancer
BeiGene
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Mon, 01/11/21 - 06:56 pm
Novartis
BeiGene
tiselizumab
cancer
drug development
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market
BioSpace
Thu, 01/23/20 - 12:22 pm
BeiGene
tiselizumab
non-small cell lung cancer
Merck
Keytruda
Number 7? Celgene partner BeiGene joins the crowd with stellar PD-1/L1 data from a pivotal test
Endpoints
Mon, 07/23/18 - 09:45 am
Celgene
BeiGene
tiselizumab
Hodgkin's lymphoma